Ulusal Venöz Tromboembolizm Profilaksi ve Tedavi Kılavuzu 2010
Ulusal Venöz Tromboembolizm Profilaksi ve Tedavi Kılavuzu 2010
Ulusal Venöz Tromboembolizm Profilaksi ve Tedavi Kılavuzu 2010
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Venöz <strong>Tromboembolizm</strong>123<br />
60. The European Stroke Organisation (ESO) Executi<strong>ve</strong> Committee and the ESO Writing<br />
Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic<br />
Attack 2008. Cerebrovasc Dis 2008;25:457-507.<br />
61. Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, et al. The<br />
efficacy and safety of enoxaparin <strong>ve</strong>rsus unfractionated heparin for the pre<strong>ve</strong>ntion of<br />
<strong>ve</strong>nous thromboembolism after acute ischaemic stroke (PREVAIL Study): an openlabel<br />
randomised comparison. Lancet 2007;369:1347-1355.<br />
62. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and<br />
thrombolytic therapy for ischemic stroke: American College of Chest Physicians<br />
Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:630S-669S.<br />
63. McGarry LJ, Stokes ME, Thompson D. Outcomes of thromboprophylaxis with<br />
enoxaparin vs. unfractionated heparin in medical inpatients Thrombosis Journal<br />
2006;4(17):1-9.<br />
64. National Clinical Guideline Centre - Acute and Chronic Conditions (formerly the<br />
National Collaborating Centre for Acute Care). Venous thromboembolism: reducing<br />
the risk of <strong>ve</strong>nous thromboembolism (deep <strong>ve</strong>in thrombosis and pulmonary embolism)<br />
in patients admitted to hospital. London, 2009.<br />
65. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic Therapy for Venous<br />
Thromboembolic Disease. American College of Chest Physicians Evidence-Based<br />
Clinical Practice Guidelines (8th Edition). Chest 2008;133;454-545.<br />
66. Falanga A, Marchetti M. Venous thromboembolism in the hematologic malignancies.<br />
J Clin Oncol. 2009;27(29):4848-57.<br />
67. Ku GH, White RH, Chew HK, Har<strong>ve</strong>y DJ, Zhou H, Wun T. Venous thromboembolism<br />
in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood<br />
2009; 113:3911-3917<br />
68. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.<br />
Thromboembolism in hospitalized neutropenic cancer patients. J Clin<br />
Oncol.2006;24(3):484-90.<br />
69. Demir M. Dahili hastal›klar grubunda <strong>ve</strong>nöz tromboembolizm oluflumunun<br />
engellenmesi (tromboproflaksi). Prospect 2003;5(2):34-38.<br />
70. Zhu T, Martinez I, Emmerich I. Venous thromboembolism: risk factors for recurrence.<br />
Arterioscler Vasc Biol 2009;29:298-310.<br />
71. Van Dongen CJJ, van der Belt AGM, Prins MH, Lensing AWA. Fixed dose<br />
subcutaneous low molecular weight heparins <strong>ve</strong>rsus adjusted dose unfractionated<br />
heparin for <strong>ve</strong>nous thromboembolism. Cochrane Database Syst Rev 2004.<br />
72. Kurto¤lu M. Long-term efficacy and safety of once-daily enoxaparin plus warfarin<br />
for the outpatient ambulatory treatment of lower-limb deep <strong>ve</strong>in thrombosis in the<br />
TROMBOTEK trial. Journal of Vascular Surgery. <strong>2010</strong> Aug 21, e-pub.<br />
73. Watson LI, Armon MP. Thrombolysis for acute deep <strong>ve</strong>in thrombosis. Cochrane<br />
Database Syst Rev 2004; CD002783.<br />
74. Demir M, Öztürk E. Kan suland›r›c›lar›na ba¤l› kanamalar. Ed: Ertekin C, Gülo¤lu<br />
R, Tavilo¤lu K. Acil Cerrahi. Nobel T›p Kitabevleri ‹stanbul, 2009 ss. 667-75. ISBN: 978-<br />
9944-5104-2-4.
Change language